Outcome

Hyperbaric oxygen therapy (HBOT) significantly improved heart function in aging pre-diabetic rats. By reducing oxidative stress inflammation apoptosis and mitochondrial dysfunction while increasing autophagy HBOT resulted in better cardiac health.

Introduction

Hyperbaric oxygen therapy (HBOT) has demonstrated significant benefits in improving heart function in aged pre-diabetic rats. This study aimed to explore the potential of HBOT in mitigating cardiac dysfunction associated with aging and pre-diabetes conditions that are increasingly prevalent in the global population. The research involved administering 100% oxygen at 2 atmospheres absolute (ATA) for 60 minutes daily over a 14-day period to aging Wistar rats induced with cardiac dysfunction through a high-fat diet and D-galactose injections. The results indicated that HBOT significantly reduced oxidative stress inflammation apoptosis and mitochondrial dysfunction while enhancing autophagy leading to improved cardiac function. Although HBOT did not fully restore cardiac function to normal levels it significantly decreased markers of cardiac aging and improved overall heart health. These findings suggest that HBOT could be a promising therapeutic approach for addressing age-related cardiac issues particularly in populations with pre-diabetes.

Results

The study demonstrated that Hyperbaric Oxygen Therapy (HBOT) significantly improved cardiac function in aged pre-diabetic rats. HBOT was administered daily for 60 minutes at 2 ATA with 100% oxygen over a period of 14 days. The therapy notably reduced oxidative stress inflammation apoptosis and mitochondrial dysfunction while enhancing autophagy.

One of the major findings was the reduction in oxidative stress and inflammation markers. These reductions were accompanied by a decrease in apoptotic cell death which collectively contributed to improved cardiac function. Although HBOT did not completely restore the heart function to normal levels it was effective in reducing the markers of cardiac aging indicating a significant improvement in overall heart health.

Furthermore HBOT led to enhanced mitochondrial function and morphology. The aging rats showed a notable improvement in mitochondrial efficiency and a reduction in dysfunctional mitochondria which are often implicated in age-related cardiac issues. This improvement in mitochondrial health is a key factor in the observed enhancement in cardiac function.

A noteworthy outcome was the increase in autophagy a process essential for cellular repair and maintenance. The therapy promoted autophagic activity which helped in clearing damaged cellular components thereby contributing to the overall improvement in cardiac function.

In conclusion HBOT significantly alleviated D-galactose-induced cardiac dysfunction in aged pre-diabetic rats primarily by improving mitochondrial function reducing oxidative damage and enhancing autophagy. These findings position HBOT as a promising treatment for mitigating age-related cardiac dysfunction particularly in pre-diabetic conditions.

Conclusion

In conclusion this study demonstrates the substantial benefits of hyperbaric oxygen therapy (HBOT) in enhancing heart function in aged pre-diabetic rats. The administration of 100% oxygen at 2 ATA for 60 minutes daily over 14 days resulted in reduced oxidative stress inflammation apoptosis and mitochondrial dysfunction while promoting autophagy. These changes collectively contributed to improved cardiac function even though normal cardiac function was not fully restored.

The significance of these findings in the context of HBOT research is profound highlighting HBOT as a promising therapeutic strategy for age-related and metabolic disorder-induced cardiac dysfunction. The improvement in mitochondrial function and reduction in markers of cardiac aging underline HBOT’s potential to mitigate the deleterious effects of aging and pre-diabetes on heart health.

Future research should aim to validate these findings in human subjects and explore the underlying mechanisms that drive the observed benefits of HBOT. Additionally long-term studies are needed to assess the durability of HBOT’s effects and optimize treatment protocols. Overall this study strengthens the case for HBOT as a viable intervention to combat age-related cardiac issues and suggests its potential for broader clinical applications.